MacroGenics   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Rockville MD United States (2000)

Organization Overview

First Clinical Trial
2004
NCT00101972
First Marketed Drug
2020
margetuximab
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MacroGenics | MACROGENICS INC | MacroGenics, Incorporated